PinnyPeptide

GHK-Cu vs PTD-DBM

Side-by-side comparison: effects, dosing ranges, side effects, regulatory status, and reconstitution.

Peptide A

GHK-Cu

Cosmetic

Copper-binding tripeptide with potent wound-healing, skin-remodeling, and gene-regulatory properties.

Peptide B

PTD-DBM

Cosmetic

Wnt-activating peptide that blocks CXXC5 — investigational topical hair-regrowth agent.

Typical vial

50 mg

Typical dose

200-500 mcg

Half-life

~30-60 minutes (plasma)

FDA status

Not FDA approved as a drug. Widely used as a cosmetic ingred…

Typical vial

5 mg

Typical dose

Topical formulation-dependent mcg

Half-life

Variable; topical residence-time dependent

FDA status

Not FDA approved.

GHK-Cu effects

  • Stimulates collagen and elastin synthesis for skin rejuvenation
  • Promotes wound healing and tissue remodeling
  • Enhances angiogenesis and blood vessel formation
  • Modulates expression of over 4,000 genes involved in tissue repair
  • Provides antioxidant defense via superoxide dismutase activation
  • Reduces fine lines, wrinkles, and photodamage

PTD-DBM effects

  • Blocks CXXC5-Dvl interaction in hair follicles
  • Restores Wnt/β-catenin signaling
  • Promotes anagen (growth) phase reactivation
  • Synergistic with valproic acid in preclinical models
  • Investigational topical hair-regrowth agent

GHK-Cu side effects

  • Mild skin irritation with topical use (uncommon)
  • Injection site discomfort with subcutaneous administration
  • Uncommon metallic taste
  • Rare contact sensitivity in predisposed individuals

PTD-DBM side effects

  • Limited human safety data
  • Theoretical: off-target Wnt activation in non-follicle tissues
  • Possible scalp irritation with topical use
  • Long-term safety in chronic use unstudied

GHK-Cu dosing ranges

Skin rejuvenation (topical)

1-2% concentration · Once or twice daily · Ongoing

Systemic tissue support (SubQ)

200-500 mcg · Once daily · 4-6 weeks

Wound healing support (SubQ)

200-500 mcg · Once daily near wound site · 2-4 weeks

PTD-DBM dosing ranges

Topical hair regrowth research

Variable per formulation · Daily topical application to scalp · 12-24 weeks minimum for visible results

Full GHK-Cu guide → Full PTD-DBM guide →

GHK-Cu vs PTD-DBM — common questions

What is the difference between GHK-Cu and PTD-DBM?

GHK-Cu: Copper-binding tripeptide with potent wound-healing, skin-remodeling, and gene-regulatory properties. Typical dose 200-500 mcg. PTD-DBM: Wnt-activating peptide that blocks CXXC5 — investigational topical hair-regrowth agent. Typical dose Topical formulation-dependent mcg. Both fall under the Cosmetic category.

Can you stack GHK-Cu and PTD-DBM?

Stacking GHK-Cu with PTD-DBM is a protocol-design question best raised with a clinician — it depends on your goal, current bloodwork, and whether both peptides target overlapping mechanisms. Both peptides should be tracked independently with separate injection sites and timing. PinnyPeptide supports multi-peptide stacks with automatic injection site rotation.

Which is dosed more frequently, GHK-Cu or PTD-DBM?

GHK-Cu is typically dosed: Once or twice daily for Skin rejuvenation (topical); Once daily for Systemic tissue support (SubQ); Once daily near wound site for Wound healing support (SubQ). PTD-DBM is typically dosed: Daily topical application to scalp for Topical hair regrowth research.

Are GHK-Cu and PTD-DBM FDA approved?

GHK-Cu: Not FDA approved as a drug. Widely used as a cosmetic ingredient without requiring drug approval for topical formulations. PTD-DBM: Not FDA approved.

Related peptide comparisons

bpc-157 vs ghk-cuepithalon vs ghk-cughk-cu vs matrixylghk-cu vs melanotan-iighk-cu vs pal-ghkmatrixyl vs ptd-dbm

Tracking either of these?

Log doses, automate injection site rotation, and never lose track of where you last pinned. Free forever.

Get Started Free